D.E. Shaw & Co
ETNB

D.E. Shaw & Co’s 89bio ETNB Stock Holding History

D.E. Shaw & Co’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,500
Closed -$199K – 4318
2023
Q2 		$199K Buy
+10,500
New +$184K ﹤0.01% 3744

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.E. Shaw & Co's ETNB Position: Q4 2025 in Review

D.E. Shaw & Co sold out of 89bio (ETNB) in Q4 2025, closing a stake of 60,208 shares — an estimated $885K sold.

D.E. Shaw & Co first reported a position in ETNB in Q1 2022 and held it in 8 quarters. The position peaked at $7.76M in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • D.E. Shaw & Co reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 60,208 89bio shares in Q4 2025, an estimated $885K.
  • D.E. Shaw & Co first reported a position in 89bio in Q1 2022 and held it in 8 quarters.
  • D.E. Shaw & Co's 89bio position peaked at $7.76M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.